Amat-Santos, I. J., Sanchez-Luna, J. P., Abu-Assi, E., Melendo Viu, M., Cruz-Gonzalez, I., Nombela-Franco, L., . . . Investiga, D. a. T. A. V. I. (. (2022). Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial.
Citación estilo ChicagoAmat-Santos, Ignacio J., et al. Rationale and Design of the Dapagliflozin After Transcatheter Aortic Valve Implantation (DapaTAVI) Randomized Trial. 2022.
Cita MLAAmat-Santos, Ignacio J., et al. Rationale and Design of the Dapagliflozin After Transcatheter Aortic Valve Implantation (DapaTAVI) Randomized Trial. 2022.
Precaución: Estas citas no son 100% exactas.